Aurélie Scriva

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to <i>BRAF</i> Mutation and Mismatch Repair Status of the MOSAIC Study

Thierry André, Armand de Gramont, Déwi Vernerey et al. · Journal of Clinical Oncology · 2015 · 675 citations

Medicine, Molecular Genetics, Oncology +17

Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas

Renato M. Lupinacci, Anastasia R. Goloudina, Olivier Buhard et al. · Gastroenterology · 2017 · 103 citations · Full text

Medicine, Oncology, Pathology +14

Small Bowel Adenocarcinomas Complicating Crohnʼs Disease Are Associated With Dysplasia

Magali Svrcek, Gaël Piton, Jacques Cosnes et al. · Inflammatory Bowel Diseases · 2014 · 81 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study

Sarah Watson, Pierre Validire, Pascale Cervera et al. · Annals of Oncology · 2013 · 43 citations

Medicine, Oncology, Pathology +15

Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas

Jérémy Augustin, Caroline Gabignon, Aurélie Scriva et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2020 · 37 citations

Medicine, Oncology, Pathology +13